Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Lower sperm quality and testicular and epididymal structural impairment in adult rats exposed to rosuvastatin during prepuberty

Full text
Author(s):
Araujo Leite, Gabriel Adan [1] ; Sanabria, Marciana [1] ; Cavariani, Marilia Martins [1] ; Anselmo-Franci, Janete Aparecida [2] ; Felipe Pinheiro, Patricia Fernanda [3] ; Domeniconi, Raquel Fantin [3] ; Kempinas, Wilma De Grava [1]
Total Authors: 7
Affiliation:
[1] Sao Paulo State Univ UNESP, Inst Biosci, Dept Morphol, Botucatu, SP - Brazil
[2] Univ Sao Paulo, Sch Dent, Dept Morphol Stomatol & Physiol, Sao Paulo - Brazil
[3] Sao Paulo State Univ UNESP, Inst Biosci, Dept Anat, Botucatu, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: JOURNAL OF APPLIED TOXICOLOGY; v. 38, n. 6, p. 914-929, JUN 2018.
Web of Science Citations: 1
Abstract

The increase of obesity, bad eating habits and the lack of physical exercises are highly related to dyslipidemias. Rosuvastatin is a lipid-lowering drug and has been indicated to prevent cardiovascular diseases and to treat dyslipidemias due to its higher efficiency to reduce serum cholesterol concentrations. This study aimed to evaluate the reproductive adverse effects on sexual maturity due to rosuvastatin exposure in juvenile male rats during prepuberty. Three groups were randomly formed with newly weaned rats: control, whose rats received saline solution 0.9% and rosuvastatin at doses of 3 or 10mg kg(-1) day(-1), administered orally by gavage, from postnatal day 21 until preputial separation (average of 45days for controls and 49days for statin-treated animals), indicative of puberty onset. Male rats were maintained until sexual maturity and were killed on postnatal day 110. In the rosuvastatin-treated groups, the results showed diminished follicle-stimulating hormone, luteinizing hormone and testosterone concentrations, increased estradiol and prolactin concentrations, histopathologic alterations on testis and epididymis and decreased sperm quality. Moreover, statin-exposed groups showed decreased expression of androgen receptor on testis and epididymis and lower expression of aquaporin-9 on epididymal epithelium. In conclusion, administration of rosuvastatin to prepubertal male rats provoked long-term hormonal deregulation and impaired reproduction at adulthood. Prepubertal exposure to rosuvastatin promoted reduced serum follicle-stimulating hormone, luteinizing hormone and testosterone concentrations and increased serum prolactin and estradiol concentrations, leading to a hormonal deregulation on sexual maturity. Furthermore, rosuvastatin-exposed groups exhibited augmented germ cell death, decreased expression of androgen receptors on testis and epididymis and lower expression of aquaporin-9 on epididymal epithelium. In conclusion, administration of rosuvastatin to juvenile male rats impaired male reproduction at adulthood. (AU)

FAPESP's process: 11/15065-5 - Reproductive development of male rats exposed to the hypolipemic agent rosuvastatin
Grantee:Gabriel Adan Araújo Leite
Support type: Scholarships in Brazil - Master